Articles from Inspection Monitor (July 1, 2004)

Title	Author	Type	Words
483 and warning letter issued for unapproved, misbranded drug.			942
Audits focusing on computers that don't generate accurate adverse event reports: FDAer urges firms to report problems before agency learns of them.	Pickett, Joseph		1063
Central Ohio Eye Bank passes FDA inspection.			369
FDA says MTF doesn't have to abide by Part 11; no 483 issued.			439
French device firm cited in 483, warning for QA, documentation.			556
Inspection log.			629
No 483 for Midwest ear tissue bank.			570
Ohio tissue bank whizzes FDA audit.			382
U.S. Tissue and Cell operating within regulations.			365